SNMMI Press Releases
June 11, 2012
SNM Elects Frederic Fahey, DSc, as President during 2012 Annual Meeting
Director of nuclear medicine physics at Children’s Hospital Boston to focus on dose optimization
Embargoed until 10:00 AM EDT June 11, 2012
Miami Beach, Fla. —Frederic H. Fahey, DSc, director of nuclear medicine physics at Children’s Hospital Boston and associate professor of radiology at Harvard Medical School, assumed office as 2012-13 president of the Society of Nuclear Medicine (SNM). SNM introduced a new slate of officers during its 2012 Annual Meeting, June 9-13 in Miami Beach, Fla.
“As a nuclear medicine physicist, advancing a better understanding of radiation dose and risk and promoting dose optimization will be a main focus during my term as president,” Fahey noted. “Radiation dose for all nuclear medicine and molecular imaging procedures should be optimized by ensuring that the patient receives the smallest possible amount of radiopharmaceutical that will provide the necessary diagnostic information. Through education, communications, outreach and government relations, we will work to ensure that this is understood and put into practice.”
Fahey will also engage in global initiatives, collaborating with peer societies from around the world and working to expand the practice of nuclear medicine and molecular imaging in developing countries. Within the society, Fahey will call upon members to get involved and will solicit their input to ensure that SNM’s activities reflect the wants and needs of its members.
“Advancing our profession is a team effort,” Fahey said. “There is a lot to do, and I look forward to working with colleagues around the world and across the country to ensure a healthy future for the field of nuclear medicine and molecular imaging.”
Throughout his career Fahey has been active in contributing to the nuclear medicine and molecular imaging field. With more than 25 years of experience, he has served in the capacity of educator, clinical physicist and researcher in nuclear medicine. His involvement with SNM includes serving as president-elect, vice president-elect and on the board of directors. He is a member of the SNM Finance Committee and served as chair of the Scientific Program Committee for four years. Fahey is also a member of SNM’s New England Chapter.
Fahey has been the director of nuclear medicine physics at Children’s Hospital Boston since 2003 and has held an academic appointment at Harvard Medical School since 2004. He has clinical experience as a PET physicist at Wake Forest University Baptist Medical Center, Winston-Salem, N.C., where he was an associate professor of radiology. He was also a nuclear medicine physicist and an assistant professor of radiology at Georgetown University Hospital, Washington, D.C. Fahey holds a master’s degree and doctoral degree in medical radiological physics from Harvard School of Public Health and a bachelor’s degree in physics from the University of Massachusetts.
Fahey is a member of the American College of Radiology (ACR) and earlier in 2012 was installed as an ACR Fellow. He is also a member and fellow of the American Association of Physicists in Medicine. Fahey has written 80 journal articles and published 18 book chapters and review articles and serves as an expert consultant for the International Atomic Energy Agency.
Other SNM officers elected for 2012–13 are Gary Dillehay, MD, FACNM, FACR, Chicago, Ill., as president-elect, and Peter Herscovitch, MD, Bethesda, Md., as vice president-elect. SNM Technologist Section officers for 2012–13 are Brenda King, CNMT, FSNMTS, Carson, Calif., as president, and Scott Holbrook, BS, CNMT, FSNMTS, Gray, Tenn., as president-elect.
About SNM—Advancing Molecular Imaging and Therapy
SNM is an international scientific and medical organization dedicated to raising public awareness about what molecular imaging is and how it can help provide patients with the best healthcare possible. SNM members specialize in molecular imaging, a vital element of today’s medical practice that adds an additional dimension to diagnosis, changing the way common and devastating diseases are understood and treated.
SNM’s more than 17,000 members set the standard for molecular imaging and nuclear medicine practice by creating guidelines, sharing information through journals and meetings, and leading advocacy on key issues that affect molecular imaging and therapy research and practice. For more information, visit www.snm.org.